참고문헌
- Siddiqui MM, Rais-Bahrami S, Turkbey B, George AK, Rothwax J, Shakir N, et al. Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA 2015;313:390-397 https://doi.org/10.1001/jama.2014.17942
- Hambrock T, Somford DM, Hoeks C, Bouwense SA, Huisman H, Yakar D, et al. Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen. J Urol 2010;183:520-527 https://doi.org/10.1016/j.juro.2009.10.022
- Futterer JJ. Multiparametric MRI in the detection of clinically significant prostate cancer. Korean J Radiol 2017;18:597-606 https://doi.org/10.3348/kjr.2017.18.4.597
- Meng X, Rosenkrantz AB, Mendhiratta N, Fenstermaker M, Huang R, Wysock JS, et al. Relationship between prebiopsy multiparametric magnetic resonance imaging (MRI), biopsy indication, and MRI-ultrasound fusion-targeted prostate biopsy outcomes. Eur Urol 2016;69:512-517 https://doi.org/10.1016/j.eururo.2015.06.005
- Baco E, Rud E, Eri LM, Moen G, Vlatkovic L, Svindland A, et al. A randomized controlled trial to assess and compare the outcomes of two-core prostate biopsy guided by fused magnetic resonance and transrectal ultrasound images and traditional 12-core systematic biopsy. Eur Urol 2016;69:149-156 https://doi.org/10.1016/j.eururo.2015.03.041
- Venderink W, van Luijtelaar A, Bomers JG, van der Leest M, Hulsbergen-van de Kaa C, Barentsz JO, et al. Results of targeted biopsy in men with magnetic resonance imaging lesions classified equivocal, likely or highly likely to be clinically significant prostate cancer. Eur Urol 2017 Feb 28 [Epub]. https://doi.org/10.1016/j.eururo.2017.02.021
- Wegelin O, van Melick HHE, Hooft L, Bosch JLHR, Reitsma HB, Barentsz JO, et al. Comparing three different techniques for magnetic resonance imaging-targeted prostate biopsies: a systematic review of in-bore versus magnetic resonance imaging-transrectal ultrasound fusion versus cognitive registration. Is there a preferred technique? Eur Urol 2017;71:517-531 https://doi.org/10.1016/j.eururo.2016.07.041
- Arsov C, Rabenalt R, Blondin D, Quentin M, Hiester A, Godehardt E, et al. Prospective randomized trial comparing magnetic resonance imaging (MRI)-guided in-bore biopsy to MRI-ultrasound fusion and transrectal ultrasound-guided prostate biopsy in patients with prior negative biopsies. Eur Urol 2015;68:713-720 https://doi.org/10.1016/j.eururo.2015.06.008
- Ahmed HU, El-Shater Bosaily A, Brown LC, Gabe R, Kaplan R, Parmar MK, et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 2017;389:815-822 https://doi.org/10.1016/S0140-6736(16)32401-1
- Delongchamps NB, Peyromaure M, Schull A, Beuvon F, Bouazza N, Flam T, et al. Prebiopsy magnetic resonance imaging and prostate cancer detection: comparison of random and targeted biopsies. J Urol 2013;189:493-499 https://doi.org/10.1016/j.juro.2012.08.195
- Sonn GA, Natarajan S, Margolis DJ, MacAiran M, Lieu P, Huang J, et al. Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device. J Urol 2013;189:86-91 https://doi.org/10.1016/j.juro.2012.08.095
- Chelluri R, Kilchevsky A, George AK, Sidana A, Frye TP, Su D, et al. Prostate cancer diagnosis on repeat magnetic resonance imaging-transrectal ultrasound fusion biopsy of benign lesions: recommendations for repeat sampling. J Urol 2016;196:62-67 https://doi.org/10.1016/j.juro.2016.02.066
- Costa DN, Kay FU, Pedrosa I, Kolski L, Lotan Y, Roehrborn CG, et al. An initial negative round of targeted biopsies in men with highly suspicious multiparametric magnetic resonance findings does not exclude clinically significant prostate cancer-preliminary experience. Urol Oncol 2017;35:149. e15-e149.e21 https://doi.org/10.1016/j.urolonc.2016.11.006
- Schimmoller L, Blondin D, Arsov C, Rabenalt R, Albers P, Antoch G, et al. MRI-guided in-bore biopsy: differences between prostate cancer detection and localization in primary and secondary biopsy settings. AJR Am J Roentgenol 2016;206:92-99 https://doi.org/10.2214/AJR.15.14579
- Penzkofer T, Tuncali K, Fedorov A, Song SE, Tokuda J, Fennessy FM, et al. Transperineal in-bore 3-T MR imagingguided prostate biopsy: a prospective clinical observational study. Radiology 2015;274:170-180 https://doi.org/10.1148/radiol.14140221
- Weinreb JC, Barentsz JO, Choyke PL, Cornud F, Haider MA, Macura KJ, et al. PI-RADS prostate imaging - reporting and data system: 2015, version 2. Eur Urol 2016;69:16-40 https://doi.org/10.1016/j.eururo.2015.08.052
- Roethke MC, Kuru TH, Schultze S, Tichy D, Kopp-Schneider A, Fenchel M, et al. Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-guided biopsy at 3.0 Tesla. Eur Radiol 2014;24:344-352 https://doi.org/10.1007/s00330-013-3017-5
- Osses DF, van Asten JJ, Kieft GJ, Tijsterman JD. Prostate cancer detection rates of magnetic resonance imaging-guided prostate biopsy related to Prostate Imaging Reporting and Data System Score. World J Urol 2017;35:207-212 https://doi.org/10.1007/s00345-016-1874-7
- Felker ER, Lee-Felker SA, Feller J, Margolis DJ, Lu DS, Princenthal R, et al. In-bore magnetic resonance-guided transrectal biopsy for the detection of clinically significant prostate cancer. Abdom Radiol (NY) 2016;41:954-962 https://doi.org/10.1007/s00261-016-0750-7
- Pokorny MR, de Rooij M, Duncan E, Schroder FH, Parkinson R, Barentsz JO, et al. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. Eur Urol 2014;66:22-29 https://doi.org/10.1016/j.eururo.2014.03.002
- Le Nobin J, Orczyk C, Deng FM, Melamed J, Rusinek H, Taneja SS, et al. Prostate tumour volumes: evaluation of the agreement between magnetic resonance imaging and histology using novel co-registration software. BJU Int 2014;114(6b):E105-E112 https://doi.org/10.1111/bju.12750
- Futterer JJ, Briganti A, De Visschere P, Emberton M, Giannarini G, Kirkham A, et al. Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature. Eur Urol 2015;68:1045-1053 https://doi.org/10.1016/j.eururo.2015.01.013
- Abd-Alazeez M, Kirkham A, Ahmed HU, Arya M, Anastasiadis E, Charman SC, et al. Performance of multiparametric MRI in men at risk of prostate cancer before the first biopsy: a paired validating cohort study using template prostate mapping biopsies as the reference standard. Prostate Cancer Prostatic Dis 2014;17:40-46 https://doi.org/10.1038/pcan.2013.43
- Schimmoller L, Quentin M, Blondin D, Dietzel F, Hiester A, Schleich C, et al. Targeted MRI-guided prostate biopsy: are two biopsy cores per MRI-lesion required? Eur Radiol 2016;26:3858-3864 https://doi.org/10.1007/s00330-016-4266-x
피인용 문헌
- A Glimpse on Trends and Characteristics of Recent Articles Published in the Korean Journal of Radiology vol.20, pp.12, 2019, https://doi.org/10.3348/kjr.2019.0928